Atlas Trials

A Trial to Assess the Antipsychotic Efficacy of ITI-007

Clinical trial NCT02282761 · COMPLETED

Trial details

NCT number
NCT02282761
Sponsor
Intra-Cellular Therapies, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2014-11-01
Primary completion
2015-07-01
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.